@Jamieaaronmoore

Scientist by day, who knows what by night!

 Norfolk
Joined November 2018
  • Tweets77
  • Following87
  • Followers66
12Media
We are driving more inward #investment & generating more highly skilled jobs, according to @CR_UK’s commissioned report published today, demonstrating Cancer Research Horizons’ importance in the #lifescience ecosystem. Read our CBO Tony Hickson’s take: bit.ly/3OTzMw6
1
6
1
9
Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis: buff.ly/3IOQ2M9 In this #Commentary, William Brian Dalton, Gabriel Ghiaur and Linda Resar @HopkinsMedicine highlight the role for LAP in suppressing AML via STING activation.
3
5
13
LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia: buff.ly/3txVH2G @Rushworthlab @jamiearonmoore @uniofeastanglia #Hematology #Oncology
5
1
17
Research co-funded by Rosetrees at the University of East Anglia and Quadram Institute has shown that macrophages could be programmed to attack cancer cells via a protein known as STING (Stimulator of interferon genes), a well-known immune system acivator. jci.org/articles/view/153157
2
6
Check out this article from @UEAResearch about my recent publication.
UEA Research@UEAResearch1 Mar 2022
How does the body fight cancer? New research led by UEA has found the body's immune system can enhance chemotherapy - macrophages can be programmed to kill cancer cells. 👉 bddy.me/3pqYjOR @RushworthLab @UeaMed @TheQuadram @EarlhamInst @NNUH
5
11
How does the body fight cancer? New research led by UEA has found the body's immune system can enhance chemotherapy - macrophages can be programmed to kill cancer cells. 👉 bddy.me/3pqYjOR @RushworthLab @UeaMed @TheQuadram @EarlhamInst @NNUH
13
1
14
The @RushworthLab at @UniofEastAnglia investigated the role of macrophage LC3-associated phagocytosis within the bone marrow #microenvironment of acute myeloid leukemia (#AML). 🧫 Full article: 🔗 bit.ly/3qY7Sof
2
11
Extremely proud to have my first paper as primary author in @jclinicalinvest We find that LAP in BM macrophages is required for the suppression of AML through mtDNA sensing and STING activation jci.org/articles/view/153157 @RushworthLab @KrisBowles7 @uniofeastanglia @RosetreesT
10
26
Thesis submitted today! With the viva next year, I wonder what 2022 will bring? Any ideas...
2
16
Great to see our paper on modelling the metabolic shifts during cardiomyocyte differentiation and iron deficiency published online today. A nice way to end the year! – at East, England
2
9
3
33
Some great talks to at #TheFrancisCrickInstitute couldn't resist a snap.
7
Done great talks so far. Great to be here #phdlife
4
Wow. Very proud to have been awarded the @ASH_hematology Abstract Achievement Awards this year! Check out my poster, which includes a recording, at #ASH21. #3441 - LAP in BM Macrophages Suppresses AML Progression through mtDAMP Induced STING Activation.
4
3
31
Honoured to be attending and presenting at the UKMF Autumn Day. My first in person conference of my PhD! @UKmyelomaforum
1
2
1
12
Come and join me next Wednesday at 12pm where I will be presenting my research on the interplay between macrophages and AML. Everybody is welcome to join! Teams link: bit.ly/NCRN_2021 #CancerInNorwich #phdchat #PhD
Norwich Cancer Research Network@CancerInNorwich8 Sep 2021
📣Our seminar series restarts next Wednesday at 12pm. We will be joined by @Jamieaaronmoore , who will be talking about "The Interplay Between Bone Marrow Macrophages and Acute Myeloid Leukaemia". All are welcome, join via the Teams link: bit.ly/NCRN_2021 #CancerInNorwich
1
3
So honoured to be given an oral presentation at #EHA2021 which is now live! Check out my talk on mitochondrial DAMPs in multiple myeloma in the basic and translational research session! @RushworthLab @bigctweets
1
3
4
New research out today! We looked at how Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models of Acute Myeloid Leukemia. @RushworthLab @KrisBowles7 @UeaMed @uniofeastanglia biomarkerres.biomedcentral.c… – at Maine, USA

Venetoclax and Daratumumab combination treatment demonstrates pre-clinical efficacy in mouse models...

Biomarker Research - Acute myeloid leukemia (AML) remains an incurable malignancy despite recent advances in treatment. Recently a number of new therapies have emerged for the treatment of AML...

link.springer.com
1
9
1
15
Check out my work at #AACR21 E-poster video #2752. I am presenting my work on LAP in macrophages and the interactions with AML. I was gratefully awarded the AACR-Doreen J. Putrah Cancer Research Foundation Scholar-in-Training Award #phdchat @RushworthLab @RosetreesT
2
16
Delighted to have received the @ASH_hematology and @BritSocHaem abstract achievement award! If you are attending #ASHFromHome Don’t miss my oral presentation #451 2:45 p.m. Pacific time. #ASH20 #hematology @RushworthLab @KrisBowles7 – at Birstall, England
1
2
2
13
Enjoying catching up with talks on demand at #ASH20. Check out my poster #1832 on mitochondrial health in aged HSCs and join the discussion at our poster walk on thursday. @rushworthlab @KrisBowles7 @wellcometrust – at East, England
3
1
9
Load more